These endogenous DAMPS are passively released by necrotic cells or actively secreted by activated immune cells (86), bind to both TLR4 and the myeloid cell receptor CD33, and contribute to the ineffective hematopoiesis in MDS via direct and indirect effects on HSPCs (87). Here, CD33 is linked to myelodysplastic syndrome.